cinacalcet has been researched along with Calcinosis in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (43.24) | 29.6817 |
| 2010's | 19 (51.35) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Brandenburg, VM; Kramann, R; Schuh, A | 1 |
| Choukroun, G; Couchoud, C; Jacquelinet, C; Lambert, O; Mercadal, L; Metzger, M | 1 |
| Alderson, H; Bubtana, A; Chinnadurai, R; Chrysochou, C; Eddington, H; Erekosima, I; Green, D; Hegarty, J; Hutchison, A; Ibrahim, ST; Kalra, PA | 1 |
| Cannavò, R; Cestone, G; Cirillo, L; Cutruzzulà, R; Dattolo, PC; Errichiello, C; Gallo, P; Gregori, M; Mehmetaj, A; Sorrentino, A | 1 |
| Matuszkiewicz-Rowińska, J; Staszków, M; Wojtaszek, E; Żebrowski, P | 1 |
| Kitazono, T; Tsuruya, K; Yamada, S | 1 |
| du Buf-Vereijken, PW; Manamley, N; Potter van Loon, BJ; Reichert, LJ; Smak Gregoor, PJ; Vervloet, MG | 1 |
| Bellasi, A; Floege, J; Goodman, W; Pétavy, F; Raggi, P; Reiner, M | 1 |
| Ito, T; Iwashita, Y; Shigematsu, T | 1 |
| Al-ani, M; Kelly, CD; Parperis, K | 1 |
| Arampatzis, S; Bachtler, M; Block, GA; Chertow, GM; Floege, J; Jahnen-Dechent, W; Ma, X; Parfrey, P; Pasch, A; Smith, ER | 1 |
| Kawata, T; Kobayashi, N; Koyama, C; Miyata, S; Nagano, N; Obi, M; Wada, M; Wakita, S | 1 |
| Fernández Giráldez, ED | 1 |
| Fujii, M; Maeda, K; Mizutani, R; Myochin, H; Narita, M; Ohbayashi, T; Tsuruta, Y | 1 |
| Al-Aly, Z | 1 |
| Alonso, M; Andrés, E; Ballarín, J; Bover, J; Canal, C; Farré, N; Olaya, MT; Quílez, B | 1 |
| Yokoyama, K | 2 |
| Cattley, R; Davis, J; Henley, C; Lane, N; Li, X; Martin, D; Miller, G; Shalhoub, V; Shatzen, E; Yao, W | 1 |
| Block, GA; Chertow, GM; Csiky, B; Dehmel, B; Downey, G; Floege, J; Goodman, WG; Lopez, N; Moustafa, M; Naso, A; Nossuli, K; Raggi, P; Torres, PU | 1 |
| Almirall, J; Castañé, E; Gallardo, X | 1 |
| Taniguchi, M | 1 |
| Koiwa, F; Maruta, Y | 1 |
| Fujii, N; Hamano, T; Imai, E; Isaka, Y; Matsui, I; Mikami, S; Rakugi, H; Tomida, K | 1 |
| Chertow, GM; Csiky, B; Dehmel, B; Downey, G; Floege, J; Goodman, WG; Lopez, N; Moustafa, M; Naso, A; Nossuli, K; Raggi, P; Torres, PU | 1 |
| Lewin, E; Olgaard, K; Silver, J | 1 |
| Jung, S; Krämer, S; Müller, D; Peters, H; Querfeld, U; Rudolph, B | 1 |
| Barros, X; Campistol, JM; Durán, CE; Paschoalin, RP; Soler, M; Torregrosa, JV | 1 |
| Sunder, S; Venkataramanan, K; Verma, H | 1 |
| Matuszkiewicz-Rowińska, J | 1 |
| Cattley, RC; Colloton, M; Henley, C; Lacey, D; Martin, D; Shatzen, E; Towler, DA | 1 |
| Choukroun, G; Esper, NE; Fournier, A; Harbouche, L; Massy, Z; Monge, M; Morinière, P; Shahapuni, I | 1 |
| Cunningham, J | 1 |
| Imanishi, Y; Inaba, M | 1 |
| Arias, M; de Francisco, AL; Palomar, R; Piñera, C | 1 |
| Iseki, K | 1 |
| Pedrini, LA; Ruggiero, P; Zerbi, S | 1 |
15 review(s) available for cinacalcet and Calcinosis
| Article | Year |
|---|---|
Valvular Calcification in Chronic Kidney Disease.
Topics: Aortic Valve; Aortic Valve Stenosis; Calcinosis; Calcium-Regulating Hormones and Agents; Chelating Agents; Cinacalcet; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Renal Insufficiency, Chronic; Sevelamer; Transcatheter Aortic Valve Replacement; Vitamin K | 2019 |
Cinacalcet for secondary hyperparathyroidism: from improved mineral levels to improved mortality?
Topics: Bone Density; Calcimimetic Agents; Calcinosis; Calcium; Cinacalcet; Heart Valve Diseases; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone | 2013 |
[Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
Topics: Bone and Bones; Bone Diseases, Metabolic; Calcimimetic Agents; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Cinacalcet; Ferric Compounds; Fractures, Bone; Humans; Minerals; Parathyroidectomy; Phosphates; Phosphorus, Dietary; Renal Insufficiency, Chronic; Risk Factors; Sevelamer | 2016 |
[Clinical advances in vascular calcification].
Topics: Aged; Animals; Atherosclerosis; Calcinosis; Chronic Disease; Cinacalcet; Coronary Artery Disease; Diabetes Complications; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Diseases; Mice; Mice, Knockout; Multicenter Studies as Topic; Naphthalenes; Polyamines; Randomized Controlled Trials as Topic; Renal Artery; Sevelamer; Tomography, Spiral Computed; Tomography, X-Ray Computed; Vascular Diseases | 2008 |
The new role of calcimimetics as vasculotropic agents.
Topics: Aniline Compounds; Calcinosis; Calcium; Cardiovascular Diseases; Cinacalcet; Humans; Naphthalenes; Phenethylamines; Propylamines; Receptors, Calcium-Sensing | 2009 |
Update on the treatment of chronic kidney disease-mineral and bone disorder.
Topics: Aluminum Compounds; Calcinosis; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Dietetics; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Nephrology; Nutrition Assessment; Nutritive Value; Parathyroidectomy; Patient Care Team; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Vitamin D | 2009 |
[Chronic kidney disease (CKD) and bone. Vascular calcification in CKD].
Topics: Animals; Calcinosis; Calcium; Chelating Agents; Chronic Disease; Cinacalcet; Diphosphonates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperphosphatemia; Kidney Diseases; Naphthalenes; Phosphates; Polyamines; Prognosis; Randomized Controlled Trials as Topic; Rats; Sevelamer; Vascular Diseases | 2009 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality].
Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Humans; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Polyamines; Prognosis; Risk; Sevelamer; Survival Rate; Vascular Diseases; Vitamin D | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].
Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Vascular Diseases; Vitamin D | 2010 |
[New aspects in the management of renal osteodystrophy].
Topics: Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Controlled Clinical Trials as Topic; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phosphates; Polyamines; Polyethylenes; Sevelamer | 2004 |
[Management of secondary hyperparathyroidism].
Topics: Aniline Compounds; Calcinosis; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Design; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phenethylamines; Phosphorus; Polyamines; Practice Guidelines as Topic; Propylamines; Receptors, Calcium-Sensing; Sevelamer; Vascular Diseases; Vitamin D | 2005 |
[Secondary hyperparathyroidism].
Topics: Adsorption; Blood Vessels; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diagnosis, Differential; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intralesional; Kidney Failure, Chronic; Naphthalenes; Osteitis; Parathyroidectomy; Phosphorus; Prognosis; Renal Dialysis; Vitamin D | 2006 |
Impact of treatment with calcimimetics on hyperparathyroidism and vascular mineralization.
Topics: Calcinosis; Calcium; Chronic Disease; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Vascular Diseases | 2006 |
[Basic and clinical aspects of calcimimetics. Calcimimetics and vascular calcification].
Topics: Animals; Blood Vessels; Calcinosis; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Rats; Receptors, Calcium-Sensing | 2008 |
Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
Topics: Calcinosis; Calcium; Chelating Agents; Cinacalcet; Coronary Artery Disease; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections; Japan; Kidney Failure, Chronic; Naphthalenes; Niacinamide; Parathyroidectomy; Phosphates; Renal Dialysis; Treatment Outcome; Vitamin D | 2008 |
7 trial(s) available for cinacalcet and Calcinosis
| Article | Year |
|---|---|
A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism.
Topics: Adult; Calcinosis; Calcium-Regulating Hormones and Agents; Carotid Intima-Media Thickness; Cinacalcet; Heart Ventricles; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis | 2021 |
Presence of valvular calcification predicts the response to cinacalcet: data from the ADVANCE study.
Topics: Aged; Bone Density Conservation Agents; Calcinosis; Cinacalcet; Coronary Vessels; Dose-Response Relationship, Drug; Drug Monitoring; Female; Heart Valves; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Naphthalenes; Prognosis; Receptors, Calcium-Sensing; Renal Dialysis; Treatment Outcome; Vitamin D | 2013 |
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.
Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Calcinosis; Cardiovascular Diseases; Cause of Death; Cinacalcet; Female; Heart Failure; Hematologic Tests; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Survival Rate | 2017 |
Change in coronary artery calcification score due to cinacalcet hydrochloride administration.
Topics: Calcinosis; Cinacalcet; Coronary Artery Disease; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Time Factors; Treatment Outcome | 2008 |
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients.
Topics: Aged; Calcinosis; Cinacalcet; Coronary Artery Disease; Disease Progression; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Vascular Diseases; Vitamin D | 2010 |
Effects of cinacalcet on vascular calcification in haemodialysis patients.
Topics: Calcinosis; Cinacalcet; Coronary Artery Disease; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Treatment Outcome | 2010 |
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.
Topics: Adult; Calcinosis; Cinacalcet; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Prognosis; Prospective Studies; Renal Dialysis; Vitamin D; Vitamins | 2011 |
15 other study(ies) available for cinacalcet and Calcinosis
| Article | Year |
|---|---|
Effects of the dialysate calcium concentrations and mineral bone disease treatments on mortality in The French Renal Epidemiology and Information Network (REIN) registry.
Topics: Aged; Blood Vessels; Bone and Bones; Calcinosis; Calcium; Cinacalcet; Female; France; Hemodialysis Solutions; Humans; Lanthanum; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Registries; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Vitamin D | 2020 |
[Dystrophic Calcinosis Cutis: a rare fearsome issue of Chronic Kidney Disease].
Topics: Calcinosis; Chelation Therapy; Cinacalcet; Female; Glomerulonephritis, Membranous; Hand Deformities, Acquired; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis; Phosphorus; Skin Diseases; Vitamin D | 2018 |
Massive soft tissue calcifications in severe hyperparathyroidism secondary to end-stage renal disease.
Topics: Arthralgia; Calcinosis; Cinacalcet; Female; Hip; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Joint Diseases; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Palpation; Parathyroidectomy; Radiography; Recurrence; Shoulder | 2013 |
Regression of tumoral calcinosis after the appropriate control of a deranged mineral and bone metabolism, in conjugation with cinacalcet hydrochloride treatment, in a chronic hemodialysis patient.
Topics: Bone Diseases, Metabolic; Calcimimetic Agents; Calcinosis; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Renal Dialysis; Treatment Outcome; Uremia | 2013 |
Uraemic tumoural calcinosis.
Topics: Calcinosis; Cinacalcet; Clavicle; Female; Humans; Sevelamer; Treatment Outcome; Young Adult | 2016 |
Cinacalcet suppresses calcification of the aorta and heart in uremic rats.
Topics: Animals; Aorta; Calcinosis; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Myocardium; Naphthalenes; Parathyroid Hormone; Rats; Uremia | 2008 |
The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats.
Topics: Adenine; Animals; Biomimetic Materials; Biphenyl Compounds; Bone and Bones; Calcinosis; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Hyperplasia; Male; Molecular Weight; Naphthalenes; Organ Size; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Rats; Rats, Sprague-Dawley; Uremia | 2009 |
Fetuin-mineral complex reflects extraosseous calcification stress in CKD.
Topics: Aged; alpha-2-HS-Glycoprotein; Biomarkers; Blood Proteins; Calcinosis; Calcium; Case-Control Studies; Chronic Disease; Cinacalcet; Coronary Artery Disease; Female; Fibrinogen; Fibronectins; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Renal Dialysis; Severity of Illness Index | 2010 |
Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD.
Topics: Bone Diseases, Metabolic; Calcinosis; Cinacalcet; Humans; Kidney Failure, Chronic; Naphthalenes; Prognosis; Renal Dialysis; Vitamin D; Vitamins | 2011 |
Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats.
Topics: Animals; Aortic Diseases; Base Sequence; Calcinosis; Calcitriol; Cardiomyopathies; Cinacalcet; Connective Tissue Growth Factor; Fibrosis; Male; Naphthalenes; Nephrectomy; Parathyroid Hormone; Parathyroidectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uremia | 2012 |
Withdrawal of cinacalcet at the time of renal transplantation is not a risk factor for allograft calcifications in the early posttransplantation period.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Biopsy; Calcimimetic Agents; Calcinosis; Cinacalcet; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Risk Factors; Spain; Time Factors; Treatment Outcome; Young Adult | 2012 |
Cervical tumoral calcinosis with secondary hyperparathyroidism in a chronic hemodialysis patient.
Topics: Calcinosis; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Parathyroidectomy; Renal Dialysis | 2013 |
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
Topics: Animals; Aortic Diseases; Calcinosis; Calcitriol; Calcium; Calcium Channel Agonists; Chronic Disease; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley | 2005 |
Cinacalcet and vascular calcifications induced by calcitriol.
Topics: Animals; Calcinosis; Calcitriol; Cinacalcet; Naphthalenes; Rats; Treatment Failure; Vascular Diseases | 2006 |
Massive soft tissue calcifications and cinacalcet.
Topics: Adult; Calcinosis; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Male; Naphthalenes | 2008 |